Cisplatin nephrotoxicity

Mechanisms and renoprotective strategies

N. Pabla, Zheng Dong

Research output: Contribution to journalReview article

840 Citations (Scopus)

Abstract

Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs, notably nephrotoxicity in the kidneys, limit the use of cisplatin and related platinum-based therapeutics. Recent research has shed significant new lights on the mechanism of cisplatin nephrotoxicity, especially on the signaling pathways leading to tubular cell death and inflammation. Renoprotective approaches are being discovered, but the protective effects are mostly partial, suggesting the need for combinatorial strategies. Importantly, it is unclear whether these approaches would limit the anticancer effects of cisplatin in tumors. Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.

Original languageEnglish (US)
Pages (from-to)994-1007
Number of pages14
JournalKidney International
Volume73
Issue number9
DOIs
StatePublished - Jan 1 2008

Fingerprint

Cisplatin
Platinum
Neoplasms
Cell Death
Inflammation
Kidney
Light
Drug Therapy
Research
Pharmaceutical Preparations
Therapeutics

Keywords

  • Apoptosis
  • Cisplatin
  • Inflammation
  • Nephrotoxicity
  • Renoprotection

ASJC Scopus subject areas

  • Nephrology

Cite this

Cisplatin nephrotoxicity : Mechanisms and renoprotective strategies. / Pabla, N.; Dong, Zheng.

In: Kidney International, Vol. 73, No. 9, 01.01.2008, p. 994-1007.

Research output: Contribution to journalReview article

@article{a64e3ace652d4b409a2530e0f319ad3f,
title = "Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies",
abstract = "Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs, notably nephrotoxicity in the kidneys, limit the use of cisplatin and related platinum-based therapeutics. Recent research has shed significant new lights on the mechanism of cisplatin nephrotoxicity, especially on the signaling pathways leading to tubular cell death and inflammation. Renoprotective approaches are being discovered, but the protective effects are mostly partial, suggesting the need for combinatorial strategies. Importantly, it is unclear whether these approaches would limit the anticancer effects of cisplatin in tumors. Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.",
keywords = "Apoptosis, Cisplatin, Inflammation, Nephrotoxicity, Renoprotection",
author = "N. Pabla and Zheng Dong",
year = "2008",
month = "1",
day = "1",
doi = "10.1038/sj.ki.5002786",
language = "English (US)",
volume = "73",
pages = "994--1007",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Cisplatin nephrotoxicity

T2 - Mechanisms and renoprotective strategies

AU - Pabla, N.

AU - Dong, Zheng

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs, notably nephrotoxicity in the kidneys, limit the use of cisplatin and related platinum-based therapeutics. Recent research has shed significant new lights on the mechanism of cisplatin nephrotoxicity, especially on the signaling pathways leading to tubular cell death and inflammation. Renoprotective approaches are being discovered, but the protective effects are mostly partial, suggesting the need for combinatorial strategies. Importantly, it is unclear whether these approaches would limit the anticancer effects of cisplatin in tumors. Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.

AB - Cisplatin is one of the most widely used and most potent chemotherapy drugs. However, side effects in normal tissues and organs, notably nephrotoxicity in the kidneys, limit the use of cisplatin and related platinum-based therapeutics. Recent research has shed significant new lights on the mechanism of cisplatin nephrotoxicity, especially on the signaling pathways leading to tubular cell death and inflammation. Renoprotective approaches are being discovered, but the protective effects are mostly partial, suggesting the need for combinatorial strategies. Importantly, it is unclear whether these approaches would limit the anticancer effects of cisplatin in tumors. Examination of tumor-bearing animals and identification of novel renoprotective strategies that do not diminish the anticancer efficacy of cisplatin are essential to the development of clinically applicable interventions.

KW - Apoptosis

KW - Cisplatin

KW - Inflammation

KW - Nephrotoxicity

KW - Renoprotection

UR - http://www.scopus.com/inward/record.url?scp=42149187768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149187768&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5002786

DO - 10.1038/sj.ki.5002786

M3 - Review article

VL - 73

SP - 994

EP - 1007

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 9

ER -